|
CBV refers to Cytoxan (cyclophosphamide), BCNU (carmustine), and VP-16 (etoposide), three drugs in a chemotherapy regimen commonly given to lymphoma patients in conjunction with stem cell therapy.〔Skeel, Roland T. ''Handbook of Cancer Chemotherapy, 6th Edition''. Philadelphia: Lipincott, Williams, & Wilkins, 2003. Page 172-3, Table 5.4: "Common preparative regimens for high-dose therapy without total-body irradiation."〕 CBV is usually given in high doses to patients who have relapsed or who have (refractory disease ) and cannot benefit from standard chemotherapy. Since a patient's bone marrow is virtually guaranteed not to survive a course of CBV, the receiving patient must receive a transplant ((allogeneic ) or autologous, depending on his or her condition) of stem cells (formerly referred to as a bone marrow transplant) to replace the patient's own hemopoietic ("blood-forming") stem cells.〔"Alternatives to Blood Transfusions for Patients." Penn Online Today. Jan./Feb. 2004. ==See also== * Cancer * Chemotherapy * Lymphoma * Stem cells * Bone marrow transplant 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「CBV (chemotherapy)」の詳細全文を読む スポンサード リンク
|